Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what progress has been made on securing an adequate supply of propranolol 80mg and 160mg modified release capsules.

The Department is aware of supply issues affecting propranolol (Bedranol SR) 80 milligrams and 160 milligrams modified release capsules due to manufacturing issues which are expected to last until at least August 2026. We have engaged with National Health Service specialist clinicians and issued comprehensive guidance on how to manage patients during this time, and to advise on alternative preparations including propranolol immediate release tablets or unlicensed imports of propranolol modified release capsules where needed.

The Department continues to work with the suppliers of the medicines and the Medicines and Healthcare products Regulatory Agency to mitigate the situation and ensure supplies are available for patients as soon as possible.